Market Cap (In AUD)
152.26 Million
Revenue (In AUD)
155.02 Million
Net Income (In AUD)
-25.32 Million
Avg. Volume
69.11 Thousand
- Currency
- AUD
- Country
- Healthcare
- Open
- -
- Prev. Close
- -
- Day Range
- -
- Year Range
- 0.675-1.325
- PE
- -
- EPS
- -
- Beta Value
- 0.678
- ISIN
- AU0000150526
- CUSIP
- -
- CIK
- -
- Shares
- -
- Earnings Annoncement
- -
Company Profile
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- CEO
- Mr. Stephen Tomisich
- Employee Count
- -
- Website
- https://www.trajanscimed.com
- Ipo Date
- 2021-06-07
- Details
- Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company operates through two segments, Analytical Products and Life Science Solutions. It offers analytical products, including syringes, GC consumables, septas, caps, liners, gas filters, and tubing products; pathology solutions; and sampling products, as well as automation systems for the analysis of biological, food, and environmental samples. The company also provides nutrition testing solutions for pathology laboratories, research and clinical trials, personalized nutrition, corporate wellness, and health insurance. In addition, it offers automation workflow solutions, micro sampling devices, and data analysis services. Trajan Group Holdings Limited was incorporated in 2011 and is headquartered in Ringwood, Australia.
More Stocks
-
MYE
-
0289
-
601375
-
APLABAplab Limited
APLAB
-
RVRF
-
KMTUYKomatsu Ltd.
KMTUY
-
SEBYYSEB SA
SEBYY
-
LSIIFLisi S.A.
LSIIF